Our-position
Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial
Search
Partnering in Retinal Health
Our partnering interests in retinal diseases offer opportunities for collaboration to complement our pipeline and advance treatment and delivery.
ACCESSIBLE_diabetic_macular_edema_and_diabetic_macular_ischemia
Diabetic_macular_edema_and_diabetic_macular-ischemia
Diabetic_macular_edema_and_diabetic_macular-ischemia.pdf
Animal Health and Animal Welfare at Boehringer Ingelheim
Cardiovascular renal and metabolic diseases infographic
tomato_and_carrot_soup.pdf
Caramelised_Figs_with_Rocket_and_Avocado.pdf
honey_and_cinnamon_cookies_recipe.pdf
Proven and trustworthy
Blood Eosinophils and COPD
Prevalence of VTE in the US and Europe.pdf
Effect_of_Tiotropium_and_Salmeterol_in_COPD_Patients_With .pdf
cancer_statistics_and_incidence_rates.pdf
infographic.bp_goals_and_measurement_0.pdf
erbb_family_blockade_and_afatinib.pdf
Blood Pressure Goals and Measurement.pdf
Unbranded illustrated factsheet.pdf
Telling my story AF and DVT PE Patient Voices
Informed decision and safe use of medications
Nerandomilast (BI 1015550)
Nerandomilast (BI 1015550)
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor